INVIVO THERAPEUTICS HOLDINGS CORP. — Form D

INVIVO THERAPEUTICS HOLDINGS CORP. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-28. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Richard ChristopherExecutive OfficerKelowna, A1
C. Ann MerrifieldDirectorWatertown, MA
Robert Ann RosenthalDirectorCambridge, MA
Richard Ann RobertsDirectorCambridge, MA
Daniel Ann MarshakDirectorCambridge, MA
Christina Ann MorrisonDirectorCambridge, MA
Heather Ann HamelExecutive OfficerCambridge, MA
Richard ToselliDirectorCambridge, MA
Richard ToselliExecutive OfficerCambridge, MA
Adam K SternDirectorNew York, NY
Peter L CokerDirectorChapel Hill, NC
Peter L CokerExecutive OfficerChapel Hill, NC
Richard J RobertsDirectorCambridge, MA
George J NolenDirectorCambridge, MA
Frank M ReynoldsDirectorCambridge, MA
Frank M ReynoldsExecutive OfficerCambridge, MA
Christi M PedraDirectorCambridge, MA
Peter A ReichardDirectorChapel Hill, NC
Peter A ReichardExecutive OfficerChapel Hill, NC

Other filings by this issuer (3)

FiledFormOfferingSold
2022-10-14D$6.2M$6.2M
2010-11-09D/A$13.0M$10.5M
2010-10-06D$7.0M

More